Abstract
Polyangiaceae belong to the suborder Sorangiineae in the order Myxococcales and comprise the genera Polyangium, Sorangium, Byssovorax, Chondromyces, and Jahnella. Members of the Polyangiaceae family are commonly terrestrial isolates, mainly from soil and decaying plant material. So far, this is the only family of myxobacteria which include cellulose-degrading strains. They are recognized by distinct morphological and chemo-physiological features, from which genus and species can be delineated. Some members of the family produce most sophisticated and complex fruiting bodies resembling treelike structure. The genomes of representatives belong to the largest in the prokaryotes and contain a high percent of G+C. All genera within the family are coherent in the 16S rRNA gene phylogeny, which appears to be correlated with phenotypic characteristics. Cellular fatty acid analysis revealed strong support for each strain’s affiliation to the corresponding taxon. Polyangiaceae are of interest for a wide range of applications. The microbial predatory lifestyle exhibited by most members has implications for environmental biocontrol. In addition, diverse novel antimicrobial and cytotoxic secondary metabolites are produced by this group. Further compounds act as anti-inflammatory, antitumor, and antiviral agents (e.g., anti-HIV). The anticancer agent epothilone was isolated from this family and is currently considered as the most successful pharmaceutical derived from the entire myxobacterial order. Recently, in some novel isolates of the Polyangiaceae, steroids and commercially valuable omega-3 and omega-6 polyunsaturated fatty acids were found.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Aicher B, Schuster T, Blumenstein L, Schmidt P, Irschik H, Jansen R, Müller R, Guenther E, Gerlach M, Tiefel M (2012) Highly potent cytotoxic conjugates of Disorazol Z linked to a LHRH receptor targeting peptide, such as AEZS-125, interfere with cell cycle progression in human cancer cell lines and suppress tumor growth in a LHRH receptor positive ovarian cancer xenograft model. Poster presented in the 24th EORTC-NCI-AACR (ENA). Symposium on molecular targets and cancer therapeutics, Dublin
Behrens J, Flossdorf J, Reichenbach H (1976) Base composition of deoxyribonucleic acid from Nannocystis exedens (Myxobacterales). Int J Syst Bacteriol 26:561–562
Berkely MJ, Curtis MA (1874) Notices of north american fungi. In: Cooke MC (ed) Grevillea, a quarterly record of cryptogamic botany and its literature, vol 33(26). Williams and Norgate, London, pp 49–64
Bode H, Müller R (2006) Analysis of myxobacterial secondary metabolism goes molecular. J Ind Microbiol Biotechnol 33:577–588
Bode H, Müller R (2008) Secondary metabolism in myxobacteria. In: Whitworth DE (ed) Myxobacteria: multicellularity and differentiation. ASM Press, Washington, DC, pp 259–282
Bode HB, Zeggel B, Silakowski B, Wenzel SC, Reichenbach H, Müller R (2003) Steroid biosynthesis in prokaryotes: identification of myxobacterial steroids and cloning of the first bacterial 2,3(S)-oxidosqualene cyclase from the myxobacterium Stigmatella aurantiaca. Mol Microbiol 47:471–481
Bollag D, McQueney PA, Zhu J, Hensens O, Koupal L, Liesch J, Goetz M, Lazarides E, Woods CM (1995) Epothilones, a new class of microtubule-stabilizing agents with a taxol-like mechanism of action. Cancer Res 55:2325–2333
Brinkhoff T, Fischer D, Vollmers J, Voget S, Beardsley C, Thole S, Mussmann M, Kunze B, Wagner-Döbler I, Daniel R, Simon M (2012) Biogeography and phylogenetic diversity of a cluster of exclusively marine myxobacteria. ISME J 6:1260–1272
Brock Neil R, Hite D, Kelrick MI, Lockhart ML, Lee K (2005) Myxobacterial biodiversity in an established oak-hickory forest and a savanna restoration site. Curr Microbiol 50:88–95
Brockman ER (1967) Fruiting myxobacteria from South Carolina coast. J Bacteriol 94:1253–1254
Brockman ER, Boyd WL (1963) Myxobacteria from soils of the Alaskan and Canadian arctic. J Bacteriol 86:605–606
Crews P, Manes LV, Boehler M (1986) Jasplakinolide, a cyclodepsipeptide from the marine sponge, Jaspis sp. Tetrahedron Lett 27:2797–2800
Dawid W (2000) Biology and global distribution of myxobacteria in soils. FEMS Microbiol Rev 24:403–427
Dawid W, Gallikowski CA, Hirsch P (1988) Psychrophilic myxobacteria from Antarctic soils. Polarforschung 58:271–278
DeLong EF, Yayanos AA (1986) Biochemical function and ecological significance of novel bacterial lipids in deep-sea prokaryotes. Appl Environ Microbiol 51:730–737
Drews G (1974) Mikrobiologisches Praktikum, 2nd edn. Springer, Berlin
Dworkin M (1996) Recent advances in the social and developmental biology of myxobacteria. Microbiol Rev 60:70–102
Erwin J, Bloch K (1964) Biosynthesis of unsaturated fatty acids in microorganisms. Science 143:1006–1012
Euzéby J (2007) List of new names and new combinations previously effectively, but not validly, published. Int J Syst Evol Microbiol 57:893–897
Faull JH (1916) Chondromyces thaxteri: a new myxobacterium. Bot Gaz 62:226–232
Fudou R, Jojima Y, Iizuka T, Yamanaka S (2002) Haliangium ochraceum gen. nov., sp. nov. and Haliangium tepidum sp. nov.: novel moderately halophilic myxobacteria isolated from coastal saline environments. J Gen Appl Microbiol 48:109–116
Garcia RO, Krug D, Müller R (2009a) Discovering natural products from myxobacteria with emphasis on rare producer strains in combination with improved analytical methods. In: Hopwood D (ed) Methods in enzymology: complex enzymes in microbial natural product biosynthesis, vol 458, part A. Academic, Burlington, pp 59–91
Garcia RO, Reichenbach H, Ring MW, Müller R (2009b) Phaselicystis flava gen. nov., sp. nov., an arachidonic acid-containing soil myxobacterium, and the description of Phaselicystidaceae fam. nov. Int J Syst Evol Microbiol 59:1524–1530
Garcia R, Gerth K, Stadler M, Dogma IJ Jr, Müller R (2010) Expanded phylogeny of myxobacteria and evidence for cultivation of the ‘unculturables’. Mol Phylogenet Evol 57:878–887
Garcia R, Pistorius D, Stadler M, Müller R (2011) Fatty acid-related phylogeny of myxobacteria as an approach to discover polyunsaturated omega-3/6 fatty acids. J Bacteriol 193:1930–1942
Gawas D, Garcia R, Huch V, Müller R (2011) A highly conjugated dihydroxylated C28 steroid from a myxobacterium. J Nat Prod 74:1281–1283
Geitler L (1924) Über Polyangium parasiticum n. sp., eine submerse, parasitische Myxobacteriaceae. Arch Protistenk 50:67–88
Geitler L (1925) Über Polyangium parasiticum n. sp., eine submerse, parasitische Myxobacteriaceae. Zeit Botan 17:600–603
Gerth K, Müller R (2005) Moderately thermophilic myxobacteria: novel potential for production of natural products. Environ Microbiol 7:874–880
Gerth K, Bedorf N, Höfle G, Irschik H, Reichenbach H (1994) The soraphens: a family of novel antifungal compounds from Sorangium cellulosum (Myxobacteria). I. Soraphen A1: fermentation, isolation, biological properties. J Antibiot 47:23–31
Gerth K, Bedorf N, Höfle G, Irschik H, Reichenbach H (1996) Epothilons A and B: Antifungal and cytotoxic compounds from Sorangium cellulosum (Myxobacteria): production, physico-chemical and biological properties. J Antibiot 49:560–563
Gerth K, Pradella S, Perlova O, Beyer S, Müller R (2003) Myxobacteria: proficient producers of novel natural products with various biological activities—past and future biotechnological aspects with the focus on the genus Sorangium. J Biotechnol 106:233–253
Herrmann M, Bohlendorf B, Irschik H, Reichenbach H, Höfle G (1998) Maracin and maracen: new types of ethynyl vinyl ether and α-chloro divinyl ether antibiotics from Sorangium cellulosum with specific activity against mycobacteria. Angew Chem Int Ed 37:1253–1255
Höfle G (2009) General aspects. In: Kinghorn AD, Falk H, Kobayashi J (eds) The epothilones—an outstanding family of anti-tumour agents: from soil to the clinic. Springer, Wien/New York, pp 5–16
Iizuka T, Jojima Y, Fudou R, Yamanaka S (1998) Isolation of myxobacteria from the marine environment. FEMS Microbiol Lett 169:317–322
Iizuka T, Jojima Y, Fudou R, Hiraishi A, Ahn JW, Yamanaka S (2003a) Plesiocystis pacifica gen. nov., sp. nov., a marine myxobacterium that contains dihydrogenated menaquinone, isolated from the pacific coasts of Japan. Int J Syst Evol Microbiol 53:189–195
Iizuka T, Jojima Y, Fudou R, Tokura M, Hiraishi A, Yamanaka S (2003b) Enhygromyxa salina gen. nov., sp. nov., a slightly halophilic myxobacterium isolated from the coastal areas of Japan. Syst Appl Microbiol 26:189–196
Iizuka T, Tokura M, Jojima Y, Hiraishi A, Yamanaka S, Fudou R (2006) Enrichment and phylogenetic analysis of moderately thermophilic myxobacteria from hot springs in Japan. Microb Environ 21:189–1999
Iizuka T, Jojima Y, Hayakawa A, Fujii T, Yamanaka S, Fudou R (2013) Pseudenhygromyxa salsuginis gen. nov., sp. nov., a myxobacterium isolated from an estuarine marsh. Int J Syst Evol Microbiol 63:1360–1369
Irschik H, Jansen R, Gerth K, Höfle G, Reichenbach H (1995) Chivosazol A, a new inhibitor of eukaryotic organisms isolated from myxobacteria. J Antibiot 48:962–966
Irschik H, Reichenbach H, Höfle G, Jansen R (2007a) The thuggacins, novel antibacterial macrolides from Sorangium cellulosum acting against selected Gram-positive bacteria. J Antibiot 60:733–738
Irschik H, Schummer D, Hofle G, Reichenbach H, Steinmez H, Jansen R (2007b) Etnangien, a macrolide-polyene antibiotic from Sorangium cellulosum that inhibits nucleic acid polymerases. J Nat Prod 70:1060–1063
Jacobi C, Reichenbach H, Tindall B, Stackerbrandt E (1996) “Candidatus comitans”, a bacterium living in coculture with Chondromyces crocatus (Myxobacteria). Int J Syst Bacteriol 46:119–122
Jacobi C, Assmus B, Reichenbach H, Stackerbrandt E (1997) Molecular evidence for association between the sphingobacterium-like organism “Candidatus comitans” and the myxobacterium Chondromyces crocatus. Appl Environ Microbiol 63:719–723
Jahn E (1924) Beitrage zur Botanischen Protistologie. I. Die Polyangiden. Gebrüder Borntraeger, Leipzig
Jansen R, Kunze B, Wray V, Reichenbach H, Jurkiewicz E, Hunsmann G, Höfle G (1991) Phenoxan: a novel inhibitor of HIV-1 infection in cell cultures from Polyangium sp., strain Pl vo19 (Myxobacteria). Liebigs Ann Chem 1991:707–708
Jansen R, Nowak A, Kunze B, Reichenbach H, Höfle G (1995) Four new carotenoids from Polyangium fumosum (myxobacteria): 3,3′,4,4′-tetradehydro-1,1′,2,2′-tetrahydro-1,1′-dihydroxy-Ψ, Ψ-carotene (di-O-demethylspirilloxanthin), its β-glucoside and glucoside fatty acid esters. Liebigs Ann 1995:873–876
Jiang D-M, Wu Z-H, Zhao J-Y, Li Y-Z (2007) Fruiting and non-fruiting myxobacteria: a phylogenetic perspective of cultured and uncultured members of this group. Mol Phylogenet Evol 44:545–552
Jiang D-M, Kato C, Zhou X-W, Wu Z-H, Sato T, Li Y-Z (2010) Phylogeographic separation of marine and soil myxobacteria at high levels of classification. Int Soc Microb Ecol 4:1520–1530
Kaiser D (1993) Roland thaxter’s legacy and the origins of multicellular development. Genetics 135:249–254
Kannan N, Taylor S, Yufeng Zhai J, Venter C, Manning G (2007) Structural and functional diversity of the microbial kinome. PLoS Biol 5:0467–0478
King D, Chen C-I, Blanchard M, Aldrige B, Anderson M, Walker R, Maas J, Hanks D, Hall M, Scott J (2005) Molecular identification of a novel deltaproteobacterium as the etiologic agent of epizootic bovine abortion (foothill abortion). J Clin Microbiol 43:604–609
Kleinig H, Reichenbach H, Achenbach H, Stadler J (1971) Carotenoid pigments of Sorangium cellulosum (Myxobacterales) including two new carotenoid glycoside esters and two new carotenoid rhamnoside. Arch Mikrobiol 78:224–233
Kofler L (1913) Die Myxobakterien der Umgebung von Wien. Sitzber kais Akad Wiss Wien math Naturw Klasse Abt 1 122:845–876
Kopp M, Irschik H, Gross F, Perlova O, Sandmann A, Gerth K, Müller R (2004) Critical variations of conjugational DNA transfer into secondary metabolite multiproducing Sorangium cellulosum strains So ce12 and So ce56: development of a mariner-based transposon mutagenesis system. J Biotechnol 107:29–40
Krzemieniewska H, Krzemieniewski S (1946) Myxobacteria of the species Chondromyces Berkeley and Curtis. Bull Acad Polon Sci Lettr Classe Sci Math Nat Sér B 1:31–48
Kühlwein H, Schlicke B (1971) Polyangium luteum krzemieniewski in pure culture. J Appl Microbiol 34:515–519
Kunze B, Jansen R, Pridzun L, Jurkiewicz E, Hunsmann G, Höfle G, Reichenbach H (1992) Phenoxan, a new oxazole-pyrone from myxobacteria: production, antimicrobial activity and its inhibition of the electron transport in complex I of the respiratory chain. J Antibiot 45:1549–1552
Kunze B, Jansen R, Pridzun L, Jurkiewicz E, Hunsmann G, Höfle G, Reichenbach H (1993) Thiangazole, a new thiazoline antibiotic from Polyangium sp. (Myxobacteria): production, antimicrobial activity and mechanism of action. J Antibiot 46:1752–1755
Kunze B, Jansen R, Sasse F, Höfle G, Reichenbach H (1995) Chondramides A D, new antifungal and cytostatic depsipeptides from Chondromyces crocatus (Myxobacteria): production, physico-chemical and biological properties. J Antibiot 48:1262–1266
Lavelle F (1995) What’s new about new tubulin/microtubules binding agents? Exp Opin Invest Drug 4:771–775
Leinenbach A, Hartmer R, Lubeck M, Kneissl B, Elnakady Y, Baessmann C, Müller R, Huber C (2009) Proteome analysis of Sorangium cellulosum employing 2D-HPLC-MS/MS and improved database searching strategies for CID and ETD fragment spectra. J Proteome Res 8:4350–4361
Li YZ, Hu W, Zhang YQ, Qiu ZJ, Zhang Y, Wu BH (2002) A simple method to isolate salt-tolerant myxobacteria from marine samples. J Microbiol Method 50:205–209
Ludwig W, Schleifer KH, Reichenbach H, Stackerbrandt E (1983) A phylogenetic analysis of the myxobacteria Myxococcus fulvus, Stigmatella aurantiaca, Cystobacter fuscus, Sorangium cellulosum and Nannocystis exedens. Arch Microbiol 135:58–62
MacRae TH, McCurdy HD (1975) Ultrastructural studies of Chondromyces crocatus vegetative cells. Can J Microbiol 21:1815–1826
McCurdy HD (1969) Light and electron microscope studies on the fruiting bodies of Chondromyces crocatus. Arch Microbiol 65:380–390
McNeil KE, Skerman VBD (1972) Examination of myxobacteria by scanning electron microscopy. Int J Syst Evol Microbiol 22:243–250
Menne B, Ruckert G (1988) Myxobakterien (Myxobacterales) in Höhlensedimenten des Hagengebirges (Nördliche Kalkalpen). Die Höhle 4:120–131
Mohr KI, Garcia R, Gerth K, Irschik H, Müller R (2012) Sandaracinus amylolyticus gen. nov., sp. nov., a starch-degrading soil myxobacterium, and description of Sandaracinaceae fam. nov. Int J Syst Evol Microbiol 62:1191–1198
Moyer CL, Dobbs FC, Karl DM (1995) Phylogenetic diversity of the bacterial community from a microbial mat at an active, hydrothermal vent system, Loihi Seamount, Hawaii. Appl Environ Microbiol 61:1555–1562
Müller R, Gerth K (2006) Development of simple media which allow investigations into the global regulation of chivosazol biosynthesis with Sorangium cellulosum So ce56. J Biotechnol 121:192–200
Mulzer J (2009) The epothilones—an outstanding family of anti-tumour agents: from soil to the clinic. Springer, Wien/New York
Nichols D, McMeekin T (2002) Biomarker techniques to screen bacteria that produce polyunsaturated fatty acids. J Microbiol Methods 48:161–170
Nichols DS, Nichols P, McMeekin TA (1993) Polyunsaturated fatty acids in Antarctic bacteria. Antarctic Sci 2:149–160
Nichols D, Bowman J, Sanderson K, Nichols CM, Lewis T, McMeekin T, Nichols P (1999) Developments with Antarctic microorganisms: culture collections, bioactivity screening, taxonomy, PUFA production and cold-adapted enzymes. Curr Opin Biotechnol 10:240–246
Ojika M, Inukai Y, Kito Y, Hirata M, Iizuka T, Fudou R (2008) Miuraenamides: antimicrobial cyclic depsipeptides isolated from a rare and slightly halophilic myxobacterium. Chem Asian J 3:126–133
Pérez J, Castañeda-García A, Jenke-Kodama H, Müller R, Muñoz-Dorado J (2008) Eukaryotic-like protein kinases in the prokaryotes and the myxobacterial kinome. Proc Natl Acad Sci USA 105:15950–15955
Peterson J (1959) New species of myxobacteria from the bark of living trees. Mycologia 51:163–172
Peterson JE (1969) Isolation, cultivation and maintenance of the myxobacteria. In: Norris JR, Ribbons DW (eds) Methods in microbiology, vol 3B. Academic, London, UK, pp 185–210
Plaza A, Garcia R, Bifulco G, Martinez JP, Hüttel S, Sasse F, Meyerhans A, Stadler M, Müller R (2012) Aetheramides A and B, potent HIV-inhibitory depsipeptides from a myxobacterium of the new genus “Aetherobacter”. Org Lett 14:2854–2857
Pradella S, Hans A, Spröer C, Reichenbach H, Gerth K, Beyer S (2002) Characterisation, genome size, and genetic manipulation of the myxobacterium Sorangium cellulosum So ce56. Arch Microbiol 178:484–492
Rachid S, Krug D, Kunze B, Kochems I, Scharfe M, Zabriskie M, Blöcker H, Müller R (2006) Molecular and biochemical studies of Chondramide formation—highly cytotoxic natural products from Chondromyces crocatus Cm c5. Chem Biol 13:667–681
Reichenbach H (1984) Myxobacteria: a most peculiar group of social prokaryotes. In: Rosenberg E (ed) Myxobacteria: development and cell interactions. Springer, New York, pp 1–50
Reichenbach H (1999a) Myxobacteria. In: Flickinger MC, Drew SW (eds) Encyclopedia of bioprocess technology: fermentation, biocatalysis, and bioseparation. Wiley, New York, pp 1823–1832
Reichenbach H (1999b) The ecology of myxobacteria. Environ Microbiol 1:15–21
Reichenbach H (2001) Myxobacteria, producers of novel bioactive substances. J Ind Microbiol Biotechnol 27:149–156
Reichenbach H (2005) Order VIII. Myxococcales. In: Brenner DJ, Krieg NR, Staley JT, Garrity GM (eds) Bergey’s manual of systematic bacteriology, vol 2, part C. Springer, New York, pp 1059–1144
Reichenbach H, Dworkin M (1981) Introduction to the gliding bacteria. In: Starr MP, Stolp H, Trüper HG, Balows A, Schlegel H (eds) The procaryotes, a handbook on habitats, isolation, and identification of bacteria, vol 1. Springer, Berlin, pp 315–327
Reichenbach H, Dworkin M (1992) The myxobacteria. In: Balows A, Trüper HG, Dworkin M, Harder W, Schleifer KH (eds) The procaryotes, 2nd edn. Springer, Berlin, pp 3416–3487
Reichenbach H, Höfle G (1993) Biologically active secondary metabolites from myxobacteria. Biotechnol Adv 11:219–277
Reichenbach H, Höfle G (1999) Myxobacteria as producers of secondary metabolites. In: Grabley S, Thiericke R (eds) Drug discovery from nature. Springer, Berlin, pp 149–179
Reichenbach H, Kleinig H (1984) Pigments of myxobacteria. In: Rosenberg E (ed) Myxobacteria: development and cell interactions. Springer, New York, pp 127–137
Reichenbach H, Lang E, Schumann P, Spröer C (2006) Byssovorax cruenta gen. nov., sp nov., nom. rev., a cellulose-degrading myxobacterium: rediscovery of ‘Myxococcus cruentus’ Thaxter 1897. Int J Syst Evol Microbiol 56:2357–2363
Ringel SM, Greenough RC, Roemer S, Connor D, von Strandtmann M (1977) Abruticin (W7783), a new antifungal antibiotic. J Antibiot 30:371–375
Sanford R, Cole J, Tiedje J (2002) Characterization and description of Anaeromyxobacter dehalogenans gen. nov., sp. nov., an aryl-halorespiring facultative anaerobic myxobacterium. Appl Environ Microbiol 68:893–900
Sarao R, McCurdy HD, Passador L (1985) Enzymes of the intermediary carbohydrate metabolism of Polyangium cellulosum. Can J Microbiol 31:1142–1146
Sasse F, Kunze B, Gronewold TM, Reichenbach H (1998) The chondramides: cytostatic agents from myxobacteria acting on the actin cytoskeleton. J Natl Cancer Inst 90:1559–1563
Schäberle TF, Goralski E, Neu E, Özlem E, Hölzl G, Dörmann P, Bierbaum G, König GM (2010) Marine myxobacteria as a source of antibiotics—comparison of physiology, polyketide-type genes and antibiotic production of three new isolates of Enhygromyxa salina. Mar Drugs 8:2466–2479
Schneiker S, Perlova O, Kaiser O, Gerth K, Alici A et al (2007) Complete genome sequence of the myxobacterium Sorangium cellulosum. Nat Biotechnol 25:1281–1289
Schulz S, Fuhlendorff J, Reichenbach H (2004) Identification and synthesis of volatiles released by the myxobacterium Chondromyces crocatus. Tetrahedron 60:3863–3872
Shimkets L, Woese CR (1992) A phylogenetic analysis of the myxobacteria: basis for their classification. Proc Natl Acad Sci USA 89:9459–9463
Shimkets L, Dworkin M, Reichenbach H (2006) The myxobacteria. In: Dworkin M, Falkow S, Rosenberg E, Schleifer K-H, Stackebrandt E (eds) The prokaryotes, vol 7, 3rd edn. Springer, Berlin, pp 31–115
Singh BN (1947) Myxobacteria in soils and compost: their distribution, number and lytic action on bacteria. J Gen Microbiol 1:1–10
Singh A, Wilson S, Ward OP (1996) Docosahexaenoic acid (DHA) production by Thraustochytrium sp., ATCC 20892. World J Microbiol Biotechnol 12:76–81
Skerman VBD, McGowan V, Sneath PHA (1980) Approved lists of bacterial names. Int J Syst Bacteriol 30:225–420
Spröer C, Reichenbach H, Stackebrandt E (1999) The correlation between morphological and phylogenetic classification of myxobacteria. Int J Syst Bacteriol 49:1255–1262
Stadler M, Roemer E, Müller R, Garcia RO, Pistorius D, Brachmann A (2010) Production of omega-3 fatty acids by myxobacteria. International Patent WO 2010, 063451A2
Steinmetz H, Irschik H, Kunze B, Reichenbach H, Höfle G, Jansen R (2007) Thuggacins, macrolide antibiotics active against Mycobacterium tuberculosis: isolation from myxobacteria, structure elucidation, conformation analysis and biosynthesis. Chem Eur J 13:5822–5832
Thaxter R (1897) Further observations on the Myxobacteriaceae. Bot Gaz 23:395–411
Thaxter R (1904) Contributions from the cryptogamic laboratory of Harvard University LVI. Notes on the Myxobacteriaceae. Bot Gaz 37:405–416
Trowitzsch W, Witte L, Reichenbach H (1981) Geosmin from earthy smelling cultures of Nannocystis exedens (Myxobacterales). FEMS Microbiol Lett 12:257–260
Tu Y, Chen GP, Wang YL (2007) Autonomously replicating plasmid transforms Sorangium cellulosum So ce90 and induces expression of green fluorescent protein. J Biosci Bioeng 104:385–390
Ward O, Singh A (2005) Omega-3/6 fatty acids: alternative sources of production. Process Biochem 40:3627–3652
Warude D, Joshi K, Harsulkar A (2006) Polyunsaturated fatty acids: biotechnology. Crit Rev Biotechnol 26:83–93
Weissman KJ, Müller R (2009) A brief tour of myxobacterial secondary metabolism. Bioorg Med Chem 17:2121–2135
Weissman KJ, Müller R (2010) Myxobacterial secondary metabolites: bioactivities and modes-of-action. Nat Prod Rep 27:1276–1295
Wenzel SC, Müller R (2009) The biosynthetic potential of myxobacteria and their impact on drug discovery. Curr Opin Drug Discov Devel 12:220–230
Yan ZC, Wang B, Li YZ, Gong X, Zhang HQ, Gao PJ (2003) Morphologies and phylogenetic classification of cellulolytic myxobacteria. Syst Appl Microbiol 26:104–109
Yano Y, Nakayama A, Yoshida K (1997) Distribution of polyunsaturated fatty acids in bacteria present in intestines of deep-sea fish and shallow-sea poikilothermic animals. Appl Environ Microbiol 63:2572–2577
Yarza P, Ludwig W, Euzéby J, Amann R, Schleifer K-H, Glöckner FO, Rosselló-Móra R (2010) Update of the all-species living-tree project based on 16S and 23S rRNA sequence analyses. Syst Appl Microbiol 33:291–299
Zabriskie TM, Klocke JE, Ireland CM, Marcus AH, Molinski TF, Faulkner DJ, Xu C, Clardy JC (1986) Jaspamide, a modified peptide from a jaspis sponge with insecticidal and antifungal activity. J Am Chem Soc 108:3123–3124
Zeggel B (1993) Steroids bei Myxobakteria. Doctoral thesis, Technical University Braunschweig, Braunschweig, p 134
Zhukova RA (1963) Aerobic cellulose bacteria of northern soils. Microbiology (Trans: Mikrobiologiya) 31:855–860
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Electronic supplementary material
Rights and permissions
Copyright information
© 2014 Springer-Verlag Berlin Heidelberg
About this entry
Cite this entry
Garcia, R., Müller, R. (2014). The Family Polyangiaceae. In: Rosenberg, E., DeLong, E.F., Lory, S., Stackebrandt, E., Thompson, F. (eds) The Prokaryotes. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-39044-9_308
Download citation
DOI: https://doi.org/10.1007/978-3-642-39044-9_308
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-39043-2
Online ISBN: 978-3-642-39044-9
eBook Packages: Biomedical and Life SciencesReference Module Biomedical and Life Sciences